相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
Emilia Canton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2011)
Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins
Michael A. Pfaller et al.
CURRENT FUNGAL INFECTION REPORTS (2011)
Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media
Maiken Cavling Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp.
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical evaluation of the sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Potential confusion regarding the term 'resistance' in epidemiological surveys
S. Simjee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Statistical methods for establishing quality control ranges for antibacterial agents in clinical and laboratory standards institute susceptibility testing
John Turnidge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Setting and revising antibacterial susceptibility breakpoints
John Turnidge et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
J Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
International surveillance of Candida spp. and Aspergillus spp.:: Report from the SENTRY Antimicrobial Surveillance Program (2003)
Shawn A. Messer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates:: Correlation with results of NCCLS M27-A2 multicenter study
E Cantón et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
G Kahlmeter et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
分享论文
